RedHill Biopharma Advances COVID-19 Antiviral Study
TipRanksApr 24 07:57 ET
Express News | RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study Of RHB-107 (Upamostat), The Study Is Expected To Be Completed By The End Of 2024
Moomoo 24/7Apr 24 07:06 ET
RedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (Vs US$46.29 Loss in FY 2022)
Yahoo FinanceApr 10 06:23 ET
RedHill Biopharma's Strategic Pivot and Financial Turnaround
TipRanksApr 8 10:27 ET
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Selected for evaluation by two U.S. government countermeasures programs for Acute Radiation Syndrome (ARS) and Sulfur Mustard exposure.
Investing.com Apr 8 09:42 ET
Express News | RedHill Biopharma FY23 EPS $0.01 Up From $(0.12) YoY Revenue $6.5M Down From $61.8M YoY
Moomoo 24/7Apr 8 09:26 ET
RedHill Biopharma 2023 Rev $6.5M >RDHL
RedHill Biopharma 2023 Rev $6.5M >RDHL
Dow JonesApr 8 09:24 ET
RedHill Biopharma Secures $1.25M in Direct Offering
TipRanksApr 4 16:57 ET
RedHill Biopharma Announces Securities Sale
TipRanksApr 3 08:00 ET
Express News | RedHill BiopharmaJazz Pharmaceuticals Completes Zanidatamab Biologics License Application For Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
Moomoo 24/7Apr 2 07:31 ET
Express News | RedHill Biopharma Announces $1.25M Registered Direct Offering at a Premium to Market Price
Moomoo 24/7Apr 2 07:10 ET
RedHill Biopharma Share Capital Increase Approved
TipRanksMar 21 16:57 ET
RedHill Biopharma Reschedules Shareholders Meeting
TipRanksMar 20 17:58 ET
RedHill Biopharma Receives New Patent For H. Pylori Treatment Talicia
RTTNewsMar 11 07:56 ET
Express News | Redhill Biopharma Announced Issue Of New U.S. Patent Covering Talicia As An All-in-one Fixed-dose Combination Of Amoxicillin, Omeprazole And Rifabutin And Its Use For Helicobacter Pylori; Expected To Provide Protection For Talicia Until Feb 12, 2034
Moomoo 24/7Mar 11 07:10 ET
Express News | Redhill Biopharma And Apogee Biotechnology's Opaganib Selected By U.S. Government's Chemical Medical Countermeasures Program And Chemical Countermeasures Research Program For A Potential Medical Countermeasure Against Inhalation Sulfur Mustard Exposure
Moomoo 24/7Mar 5 07:20 ET
Express News | RedHill Biopharma Will Be Issued U.S. Patent Number 11,918,560 Tomorrow Titled "Serine Protease Inhibitor For Treating Coronavirus Infection"
Moomoo 24/7Mar 4 12:35 ET
Express News | RedHill Biopharma Says Published Data Shows That Opaganib Protects Against Radiation-induced Lung Inflammation And Fibrosis In An In Vivo Mouse Model Of Lung Damage Following Exposure To Ionizing Radiation
Moomoo 24/7Feb 20 07:11 ET
RedHill Biopharma Files to Sell 10.6M ADS for Holders
Seeking AlphaFeb 9 16:29 ET
U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 0.64%
InvestingJan 25 16:30 ET
No Data
No Data